Search Results

Current Status of EVAR in Hong Kong

By Stephen W.K. Cheng, MS, FRCS, FRCS (Ed), FACS

Panel Discussion: What Attributes Are Necessary for the Ideal Branch Stent?

Characteristics of and challenges to designing an ideal branch stent and how it could be achieved.

With Matthew J. Eagleton, MD; Sanghyun Ahn, MD; Javairiah Fatima, MD, FACS, DFSVS; Stephen W.K. Cheng, MS, FRCS, FRCS(Ed), FACS; Martin J. Austermann, MD, PhD; Nuno V. Dias, MD, PhD; and Björn Sonesson, MD

Arch Debranching Is Best

Without sufficient long-term data on the use of chimney or branched grafts, arch debranching is the preferred treatment modality.

By Stephen W. K. Cheng, MD

Does Difficult Iliac Access Still Exist?

EVAR device profiles are getting smaller, and access techniques are becoming more refined, but are we there yet?

By Yiu Che Chan, MB BS, BSc, MD, FRCS (Eng), FRCS (Gen Surg) FCSHK, and Stephen W. K. Cheng, MB BS, MS, FRCS (Eng), FRCS (Edin), FCSHK, FHKAM

For Whom the Bell Tolls

By Tara M. Mastracci, MD, FRCSC, and Gustavo S. Oderich, MD

Essential Innovation and Clinical Trial Needs in Vascular Care

Experts from a variety of specialty backgrounds comment on hurdles and opportunities for future clinical trials to explore.

With Kendal M. Endicott, MD; Jessica P. Simons, MD, MPH; Abinaya Ramakrishnan, BA; Salma Youssef; Mona Ranade, MD; John M. Moriarty, MD, FSIR; Peter A. Schneider, MD; Amy C. Taylor, MD; Sarah B. White, MD, MS, FSIR, FCIRSE; Stephen A. Black, MD, FRCS(Ed), FEBVS; Kunal P. Raygor, MD; Mehdi Bouslama, MD, MSc; and Elad I. Levy, MD, MBA